Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Ai-Bin Liang"'
Autor:
Hang Zhou, Tuersunayi Abudureheman, Wei‐Wei Zheng, Li‐Ting Yang, Jian‐Min Zhu, Ai‐Bin Liang, Cai‐Wen Duan, Kaiming Chen
Publikováno v:
Advanced Science, Vol 11, Iss 10, Pp n/a-n/a (2024)
Abstract Chimeric antigen receptor (CAR)‐positive cell therapy, specifically with anti‐CD19 CAR‐T (CAR19‐T) cells, achieves a high complete response during tumor treatment for hematological malignancies. Large‐scale production and applicati
Externí odkaz:
https://doaj.org/article/f08fe5fb5e2c4955a313fbd9f69b08b3
Publikováno v:
Haematologica, Vol 108, Iss 8 (2023)
Chimeric antigen receptor (CAR) T-cell therapy has emerged as a promising form of adoptive T-cell immunotherapy for selected hematologic malignancies including leukemia, lymphoma and multiple myeloma. China has become the country with the largest num
Externí odkaz:
https://doaj.org/article/ad19d1b129e54d309894580c7329b28f
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-17 (2021)
Abstract Background Despite of the frequently reported Dnmt3a abormality in classical myeloproliferative neoplasms (cMPNs) patients, few research explores how the Dnmt3a is regulated by Jak2V617F mutation. In this study, we have investigated how the
Externí odkaz:
https://doaj.org/article/0508c5a360064f219d38eced76fdc41e
Autor:
Min-Min Lou, Xiao-Qiang Tang, Guang-Ming Wang, Jia He, Fang Luo, Ming-Feng Guan, Fei Wang, Huan Zou, Jun-Ying Wang, Qun Zhang, Ming-Jian Xu, Qi-Li Shi, Li-Bing Shen, Guo-Ming Ma, Yi Wu, Yao-Yang Zhang, Ai-bin Liang, Ting-Hua Wang, Liu-Lin Xiong, Jian Wang, Jun Xu, Wen-Yuan Wang
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-17 (2021)
Long noncoding RNAs (lncRNAs) are known to regulate the DNA damage response (DDR), however their role in the brain is less well studied. Here, the authors demonstrate a neuron-specific role for Brain Specific DNA-damage Related lncRNA1 (BS-DRL1) and
Externí odkaz:
https://doaj.org/article/865a1ae8f53243eeaebf8820e40c99bb
Autor:
Chao Tang, Ming-Hao Li, Ya-Li Chen, Hui-Ying Sun, Sheng-Li Liu, Wei-Wei Zheng, Meng-Yi Zhang, Hui Li, Wei Fu, Wen-Jun Zhang, Ai-Bin Liang, Zhong-Hua Tang, Deng-Li Hong, Bin-Bing S. Zhou, Cai-Wen Duan
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 37, Iss 1, Pp 1-14 (2018)
Abstract Background Considerable efforts have been devoted toward the uncovering of the molecular mechanisms underlying the maintenance of hematopoietic stem cells (HSCs) by the normal bone marrow (BM) niche. Previously, we demonstrated that a chemot
Externí odkaz:
https://doaj.org/article/cb81d3acaec643adb29517fd2771d6aa
Autor:
Xiu-Hua Han, Hui-Li Xu, Jun Zhu, Yuan-Fei Mao, Jiong Hu, Jian-Yi Zhu, Fang-Yuan Chen, Ju-Mei Shi, Rong Tao, Si-Guo Hao, Shi-Yang Gu, Peng Liu, Hai-Yan He, Jian Hou, Yi Ding, Ai-Bin Liang, Li Gen Liu, Qi Zhu, Yong-Hua Yao, Chun Wang
Publikováno v:
European Journal of Inflammation, Vol 17 (2019)
The characteristics of distribution of Pseudomonas aeruginosa in patients with agranulocytosis and fever in 12 hospitals in Shanghai from 2012 to 2014 were retrospectively analyzed. WHONET 5.6 software was used to analyze the results of drug sensitiv
Externí odkaz:
https://doaj.org/article/4b6eaac362ef499d907d215bd0c8498b
Chimeric antigen receptor (CAR) T cell therapy improved the prognosis of patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) significantly. Bulky disease and disease stage, as qualitative indicators of the spatial characteristic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0b8742035b61c99034cf2fda21714ba
https://doi.org/10.21203/rs.3.rs-2923034/v1
https://doi.org/10.21203/rs.3.rs-2923034/v1
Publikováno v:
Haematologica.
Chimeric antigen receptor T (CAR-T) cell therapy has emerged as a promising form of adoptive T cell immunotherapy for selected hematological malignancies (HMs) including leukemia, lymphoma and multiple myeloma. Moreover, China has become the country
Background: Although aberrant expression of long non-coding RNA (lncRNA) is associated with many human cancers, little is known about its role in the JAK2V617F-positive classic myeloproliferative neoplasms (cMPNs). Methods: In this study, we performe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93e9dcc968a4d629b825d8878ab75c8e
https://doi.org/10.21203/rs.3.rs-26428/v1
https://doi.org/10.21203/rs.3.rs-26428/v1
Autor:
Wei-Wei Zheng, Chao Tang, Cai-Wen Duan, Ya-Li Chen, Sheng-Li Liu, Wen-Jun Zhang, Hui Li, Bin-Bing S. Zhou, Zhong-Hua Tang, Ming-Hao Li, Wei Fu, Huiying Sun, Meng-Yi Zhang, Deng-Li Hong, Ai-Bin Liang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 37, Iss 1, Pp 1-14 (2018)
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research : CR
Background Considerable efforts have been devoted toward the uncovering of the molecular mechanisms underlying the maintenance of hematopoietic stem cells (HSCs) by the normal bone marrow (BM) niche. Previously, we demonstrated that a chemotherapy-in